ACADL Antikörper (Middle Region)
Kurzübersicht für ACADL Antikörper (Middle Region) (ABIN631083)
Target
Alle ACADL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- ACADL antibody was raised against the middle region of ACADL
-
Aufreinigung
- Affinity purified
-
Immunogen
- ACADL antibody was raised using the middle region of ACADL corresponding to a region with amino acids LPQERLLIADVAISASEFMFEETRNYVKQRKAFGKTVAHLQTVQHKLAEL
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ACADL Blocking Peptide, (ABIN5611873), is also available for use as a blocking control in assays to test for specificity of this ACADL antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ACADL antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ACADL (Acyl-CoA Dehydrogenase, Long Chain (ACADL))
-
Andere Bezeichnung
- ACADL
-
Hintergrund
- ACADL belongs to the acyl-CoA dehydrogenase family, which is a family of mitochondrial flavoenzymes involved in fatty acid and branched chain amino-acid metabolism. This protein is one of the four enzymes that catalyze the initial step of mitochondrial beta-oxidation of straight-chain fatty acid. Defects in this gene are the cause of long-chain acyl-CoA dehydrogenase (LCAD) deficiency, leading to nonketotic hypoglycemia.
-
Molekulargewicht
- 44 kDa (MW of target protein)
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-